These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 32869706

  • 1. Changes in PBM Business Practices in 2019: True Innovation or More of the Same?
    Motheral BR, Fairman KA.
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1325-1333. PubMed ID: 32869706
    [Abstract] [Full Text] [Related]

  • 2. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N, Duncan I, Rubinstein E, Ahmed T, Pegus C.
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [Abstract] [Full Text] [Related]

  • 3. Undocumented source of pharmacy benefit manager revenue.
    Siracuse MV, Clark BE, Garis RI.
    Am J Health Syst Pharm; 2008 Mar 15; 65(6):552-7. PubMed ID: 18319501
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of Copayment Offsets for Prescription Drugs in the United States.
    Sen AP, Kang SY, Rashidi E, Ganguli D, Anderson G, Alexander GC.
    JAMA Intern Med; 2021 Jun 01; 181(6):758-764. PubMed ID: 33779680
    [Abstract] [Full Text] [Related]

  • 5. Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy.
    Mattingly TJ, Hyman DA, Bai G.
    JAMA Health Forum; 2023 Nov 03; 4(11):e233804. PubMed ID: 37921745
    [Abstract] [Full Text] [Related]

  • 6. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P, Shepherd M, Lawson K, Rush S.
    J Manag Care Pharm; 2013 Oct 03; 19(8):602-8. PubMed ID: 24074006
    [Abstract] [Full Text] [Related]

  • 7. The spread: pilot study of an undocumented source of pharmacy benefit manager revenue.
    Garis RI, Clark BE.
    J Am Pharm Assoc (2003); 2004 Oct 03; 44(1):15-21. PubMed ID: 14965148
    [Abstract] [Full Text] [Related]

  • 8. The Effect of Florida Medicaid's State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan.
    Munshi KD, Mager D, Ward KM, Mischel B, Henderson RR.
    J Manag Care Spec Pharm; 2018 Feb 03; 24(2):124-131. PubMed ID: 29384030
    [Abstract] [Full Text] [Related]

  • 9. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV.
    J Manag Care Spec Pharm; 2014 Sep 03; 20(9):959-67. PubMed ID: 25166295
    [Abstract] [Full Text] [Related]

  • 10. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M, Lawson KA, Shepherd MD.
    J Manag Care Pharm; 2007 Mar 03; 13(2):122-34. PubMed ID: 17330973
    [Abstract] [Full Text] [Related]

  • 11. Pharmacy benefit management companies.
    Taniguchi R.
    Am J Health Syst Pharm; 1995 Sep 01; 52(17):1915-7. PubMed ID: 8528857
    [Abstract] [Full Text] [Related]

  • 12. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM, Papshev D, Murphy EL, Sternberg DJ, Taylor J, Barg R.
    J Manag Care Pharm; 2005 Jun 01; 11(5):410-5. PubMed ID: 15934800
    [Abstract] [Full Text] [Related]

  • 13. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS, Avorn J, Sarpatwari A.
    JAMA; 2005 Jun 01; 316(8):858-71. PubMed ID: 27552619
    [Abstract] [Full Text] [Related]

  • 14. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH.
    J Clin Pharm Ther; 2016 Feb 01; 41(1):64-9. PubMed ID: 26778812
    [Abstract] [Full Text] [Related]

  • 15. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC, Christofferson S, Humble CG, Wegner SE, Feaganes JR, Trygstad TK.
    J Manag Care Pharm; 2010 May 01; 16(4):250-63. PubMed ID: 20433216
    [Abstract] [Full Text] [Related]

  • 16. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H, Bornstein SS, Health and Public Policy Committee of the American College of Physicians.
    Ann Intern Med; 2019 Dec 03; 171(11):823-824. PubMed ID: 31711103
    [Abstract] [Full Text] [Related]

  • 17. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.
    J Manag Care Pharm; 2012 Dec 03; 18(9):690-700. PubMed ID: 23206212
    [Abstract] [Full Text] [Related]

  • 18. Measuring economic impact of applying daily average consumption limits.
    Flavin BM, Nishida LM, Karbowicz SH, Renner ME, Leonard RJ.
    J Manag Care Pharm; 2014 Feb 03; 20(2):159-64. PubMed ID: 24456317
    [Abstract] [Full Text] [Related]

  • 19. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
    Dickson S, Reynolds I.
    JAMA Netw Open; 2019 Jul 03; 2(7):e196541. PubMed ID: 31276176
    [Abstract] [Full Text] [Related]

  • 20. Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?
    Lyles A.
    Pharmacoeconomics; 2017 May 03; 35(5):493-500. PubMed ID: 28210864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.